共 136 条
- [1] Cai B, Guo Z, Yan Q, Et al., Clinical features and risk factors of primary Sjögren’s syndrome complicated with severe pneumonia: a case-control study, Clin Rheumatol, 43, 5, pp. 1665-1674, (2024)
- [2] Seror R, Chiche L, Beydon M, Et al., Estimated prevalence, incidence and healthcare costs of Sjögren’s syndrome in France: a national claims-based study, RMD Open, 10, 1, (2024)
- [3] Conrad N, Misra S, Verbakel JY, Et al., Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK, Lancet, 401, 10391, pp. 1878-1890, (2023)
- [4] Beydon M, McCoy S, Nguyen Y, Et al., Epidemiology of Sjögren syndrome, Nat Rev Rheumatol, 20, 3, pp. 158-169, (2024)
- [5] Chowdhury F, Tappuni A, Bombardieri M., Biological therapy in primary Sjögren’s syndrome: effect on salivary gland function and inflammation, Front Med, 8, (2021)
- [6] Bodewes ILA, Bjork A, Versnel MA, Wahren-Herlenius M., Innate immunity and interferons in the pathogenesis of Sjögren’s syndrome, Rheumatology, 60, 6, pp. 2561-2573, (2021)
- [7] Kawka L, Felten R, Schleiss C, Et al., Alteration of innate lymphoid cell homeostasis mainly concerns salivary glands in primary Sjögren’s syndrome, RMD Open, 9, 2, (2023)
- [8] Chivasso C, Sarrand J, Perret J, Et al., The involvement of innate and adaptive immunity in the initiation and perpetuation of Sjögren’s syndrome, Int J mol Sci, 22, 2, (2021)
- [9] Brkic Z, Versnel MA., Type I IFN signature in primary Sjögren’s syndrome patients, Expert Rev Clin Immunol, 10, 4, pp. 457-467, (2014)
- [10] Witas R, Shen Y, Nguyen CQ., Bone marrow-derived macrophages from a murine model of Sjögren’s syndrome demonstrate an aberrant, inflammatory response to apoptotic cells, Sci Rep, 12, 1, (2022)